Showing 4021-4030 of 4062 results for "".
- Ophthalmic OR Microscope Market to See More Than 6 Percent Growth over Next Five Yearshttps://modernod.com/news/ophthalmic-or-microscope-market-to-see-more-than-6-percent-growth-over-next-five-years/2480110/Market Scope expects the global ophthalmic operating room (OR) microscope market to grow at a healthy pace of more than 6 percent over the next 5 years, as 2018 revenues of $403 million climb to nearly $548 million by 2023. Revenues will rise most sharply in Latin America and other develop
- Coburn Technologies Announces New Location for Corporate Headquartershttps://modernod.com/news/coburn-technologies-announces-new-location-for-corporate-headquarters/2480113/Coburn Technologies announced the relocation of their corporate headquarters to a newly renovated, modern facility in South Windsor, Connecticut. Effective July 23, 2018, Coburn Technologies will operate from their new location – 83 Gerber Road West, South Windsor, Connecticut, 06074.
- Ultrasonic Phaco Remains Dominant, but New Technologies Ready to Challengehttps://modernod.com/news/ultrasonic-phaco-remains-dominant-but-new-technologies-ready-to-challenge/2480114/Market Scope expects surgeons to perform nearly 18.5 million phaco procedures globally in 2018, and dedicated packs and accessories will make up more than 72 percent of the $1.6 billion in global cataract equipment revenues. Two factors will fuel modest growth in the cataract equipment mar
- Orasis Pharmaceuticals Closes $13 Million Series B Financinghttps://modernod.com/news/orasis-pharmaceuticals-closes-13-million-series-b-financing/2480119/Privately-held Orasis Pharmaceuticals announced the closing of a $13 million Series B financing to be used to advance Orasis’s lead product candidate, CSF-1, an eye drop being developed for the treatment of presbyopia symptoms, through completion of its phase 2b clinical trial. The proceeds will
- Optovue Announces Retirement of Industry Veteran John Hawleyhttps://modernod.com/news/optovue-announces-retirement-of-industry-veteran-john-hawley/2480137/Optovue announced the retirement of renowned industry veteran John Hawley, the company’s senior vice president of global sales. Mr. Hawley will retire on July 1, 2018, and remain with Optovue in an advisory role. “For the past 10 years, I have worked side-by-side with John as we built Opto
- BioTime Further Expands OpRegen Clinical Trial in Dry AMD With the Opening of Two Additional US Siteshttps://modernod.com/news/biotime-further-expands-opregen-clinical-trial-in-dry-amd-with-the-opening-of-two-additional-us-sites/2480141/BioTime announced the expansion of its ongoing phase 1/2a clinical trial for OpRegen, with the addition of two new U.S. sites that are expected to begin treating patients later this quarter. “The addition of these two leading U.S. clinical trial sites is in addition to our current two site
- Wize Pharma Announces Presentation of New Data on LO2A in the Treatment of Dry Eye Syndrome in Patients with Sjögren’s Syndromehttps://modernod.com/news/wize-pharma-announces-presentation-of-new-data-on-lo2a-in-the-treatment-of-dry-eye-syndrome-in-patients-with-sjogrens-syndrome/2480143/Wize Pharma announced recently reported new data on a formula known as LO2A, a product that Wize has in-licensed certain rights to purchase, market, sell and distribute. The poster presentation presented at the Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting
- Ex-Valeant Executive Guilty of Taking Pharmacy CEO’s Bribehttps://modernod.com/news/ex-valeant-executive-guilty-of-taking-pharmacy-ceos-bribe/2480147/A former Valeant Pharmaceuticals executive was found guilty of accepting a $10 million bribe for manipulating the company’s takeover of a startup mail-order pharmacy in 2014, according to a
- Telescope Implant for End-State Macular Degeneration Now on the Federal Supply Schedule and Available at VA Hospitalshttps://modernod.com/news/telescope-implant-for-end-state-macular-degeneration-now-on-the-federal-supply-schedule-and-available-at-va-hospitals/2480149/VisionCare announced that MellingMedical will distribute the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) to Department of Veteran’s Affairs hospitals, military hospitals, and other federal government healthcare facilities in the United States. MellingMedical provides medical su
- Study Compares the Accuracy of Subjective Refraction Using a Vmax Vision’s VASR vs. Traditional Refractionhttps://modernod.com/news/study-compares-the-accuracy-of-subjective-refraction-using-a-vmax-visions-vasr-vs-traditional-refraction/2480157/A comparison study reported at ARVO 2018, conducted by Drs. Christopher Lievens, Christina Newman, Alan Kabat, and optometry student Jacob Weber at the Southern College of Optometry (SCO), included 50 healthy subjects